Karin Rockwitz
Goslar, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Comparative risk of incident malignancies in rheumatoid arthritis patients treated with Janus kinase inhibitors or bDMARDs: observational data from the German RABBIT register.
Journal: Annals of the rheumatic diseases
Published: January 14, 2025
Sensitivity and Specificity of Autoantibodies Against CD74 in Nonradiographic Axial Spondyloarthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: June 19, 2017
Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs.
Journal: Annals of the rheumatic diseases
Published: April 22, 2016
Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis.
Journal: Arthritis research & therapy
Published: March 26, 2016
Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience.
Journal: Patient preference and adherence
Published: August 16, 2014
Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study.
Journal: Annals of the rheumatic diseases
Published: June 29, 2012
Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
Journal: Annals of the rheumatic diseases
Published: May 16, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026